clinical trial · NCT06577519
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Jiangsu vcare pharmaceutical technology co., LTD·phase3·recruiting·n = 1,000
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)VicagrelClopidogrel
brief summary
This is a multi-center, randomized, double-blind, double-dummy, parallel-controled, phase III trial, aiming to evaluate the effectiveness and safety of long-term continuous administration of Vicagrel capsules in ACS patients undergoing PCI.
started
Sep 6, 2024
primary completion
Dec 30, 2026
completion
Dec 30, 2026
last updated
Jul 27, 2026
official title
Efficacy and Safety of Vicagrel in Patients With With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI): a Multi-center, Randomized, Double-blind, Double-dummy , Parallel-controlled, Phase III Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol